1 Min Read
Oct 16 (Reuters) - Cannimed Therapeutics Inc
* Cannimed Therapeutics Inc - initiated production of CanniMed capsules, following receipt of production license granted by health Canada Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.